11/19/2025
At Piramal Pharma Solutions, our focus on quality and innovation continues to guide how we support partners in advancing complex therapeutics.
We are pleased to announce that our Grangemouth, UK facility has received updated MHRA GMP certificates, further strengthening its robust regulatory foundation and bioconjugation capabilities.
The certificates cover all operations across the Helix building, including its warehouse and laboratory areas, following a successful compliance review and desktop inspection. With this update, the site remains fully equipped to support clinical and commercial drug substance development, manufacturing, and testing with precision and reliability.
This achievement also reinforces Grangemouth’s critical role in ADCelerate™, our integrated pathway that accelerates the journey from R&D to GMP manufacturing. Through ADCelerate™, we help partners move to clinic faster with high-quality, end-to-end bioconjugate solutions.
With these updated certifications, PPS continues to uphold the highest standards of quality and regulatory excellence, empowering our customers to advance therapies that can make a meaningful difference for patients worldwide.
Read the full press release here:https://ppsazdevwebsitestg.blob.core.windows.net/public/uploads/generic_file_upload/191125073556-Piramal-Pharma-Solutions-Bioconjugates-Facility-in-Grangemouth,-UK-Receives-Updated-MHRA-GMP-Certificates.pdf